Brigham and Women's Hospital (BWH)

Major Adverse Cardiovascular Events and the Timing and Dose of Corticosteroids in Immune Checkpoint Inhibitor-Associated Myocarditis (2020) Zhang L, Zlotoff DA, Awadalla M, Mahmood SS, Nohria A, Hassan MZ, Thuny F, et al. Journal article EFFECT OF NINTEDANIB ON PROGRESSION OF INTERSTITIAL LUNG DISEASE (ILD) IN PATIENTS WITH AUTOIMMUNE DISEASE-RELATED ILDS: FURTHER DATA FROM THE INBUILD TRIAL (2020) Matteson E, Kelly C, Distler J, Hoffmann-Vold AM, Seibold J, Mittoo S, Distler O, et al. Conference contribution RATES OF PROGRESSION DIFFER BETWEEN STRUCTURAL PHENOTYPES OF KNEE OSTEOARTHRITIS: A SECONDARY ANALYSIS FROM THE FNIH COHORT (2020) Roemer F, Collins J, Neogi T, Crema M, Guermazi A Conference contribution SARS-CoV-2 Receptor ACE2 Is an Interferon-Stimulated Gene in Human Airway Epithelial Cells and Is Detected in Specific Cell Subsets across Tissues (2020) Ziegler CGK, Allon SJ, Nyquist SK, Mbano IM, Miao VN, Tzouanas CN, Cao Y, et al. Journal article Cardiovascular magnetic resonance in immune checkpoint inhibitor-associated myocarditis (2020) Zhang L, Awadalla M, Mahmood SS, Nohria A, Hassan MZ, Thuny F, Zlotoff DA, et al. Journal article COMPARISON OF RADIOGRAPHY, 3T AND 7T MAGNETIC RESONANCE IMAGING FOR ANALYSIS OF DISTAL RADIUS TRABECULAR BONE IN PATIENTS WITH ESTABLISHED OR SUSPECTED WRIST OSTEOARTHRITIS USING FRACTAL SIGNATURE ANALYSIS (2020) Jarraya M, Heiß R, Duryea J, Lynch J, Weber MA, Guermazi A, Uder M, Roemer F Conference contribution Results from BLASST-1 (Bladder Cancer Signal Seeking Trial) of nivolumab, gemcitabine, and cisplatin in muscle invasive bladder cancer (MIBC) undergoing cystectomy (2020) Gupta S, Sonpavde G, Weight C, McGregor BA, Gupta S, Maughan BL, Wei X, et al. Conference contribution Global Longitudinal Strain and Cardiac Events in Patients With Immune Checkpoint Inhibitor-Related Myocarditis (2020) Awadalla M, Mahmood SS, Groarke JD, Hassan MZ, Nohria A, Rokicki A, Murphy SP, et al. Journal article Bimekizumab in patients with active psoriatic arthritis: results from a 48-week, randomised, double-blind, placebo-controlled, dose-ranging phase 2b trial (2020) Ritchlin CT, Kavanaugh A, Merola JF, Schett G, Scher JU, Warren RB, Gottlieb AB, et al. Journal article Developing classification criteria for skin-predominant dermatomyositis: the Delphi process. (2020) Concha JSS, Pena S, Gaffney RG, Patel B, Tarazi M, Kushner CJ, Merola JF, et al. Journal article